Associated Papers
Comparative Analysis of a Dual DNA-RNA Panel and a DNA-Only Panel for Sarcoma: Real-World Data From a Nationwide Genomic Database.
Nakata E et al.
Cancer Science, 2026
41128349 (PubMed )
Supplement: CAS-117-156-s003.xlsx › Sheet1
Genomic landscape and preclinical models of angiosarcoma.
Benton A et al.
Molecular Oncology, 2025
New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.
Kapturska KM et al.
Veterinary and Comparative Oncology, 2023
Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis.
Mandal S et al.
Biochimica Et Biophysica Acta. Reviews on Cancer, 2021
A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene.
Khan SM et al.
Plos One, 2021
Phospholipase C families: Common themes and versatility in physiology and pathology.
Katan M et al.
Progress in Lipid Research, 2020
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease.
Momen S et al.
Cold Spring Harbor Molecular Case Studies, 2019
Identification of different mutational profiles in cancers arising in specific colon segments by next generation sequencing.
Oliveira DM et al.
Oncotarget, 2018
29844865 (PubMed )
Supplement: oncotarget-09-23960-s003.xlsx › Supplemental_Table_S2
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
Wang M et al.
Oncotarget, 2017
Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC et al.
The American Journal of Surgical Pathology, 2016
The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies.
Nguyen TD et al.
Journal of Proteomics, 2016
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Murali R et al.
Oncotarget, 2015
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H et al.
Oncotarget, 2015
A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
Kunze K et al.
Cancer Research, 2014
Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Behjati S et al.
Nature Genetics, 2014
Select a paper to view details